1. Rabiolo A, Gelormini F, Marchese A, et al. Macular perfusion parameters in different angiocube sizes: does the size matter in quantitative optical coherence tomography angiography? Invest Ophthalmol Vis Sci. 2018; 59:231–237.
Article
2. Kohner EM, Oakley NW. Diabetic retinopathy. Metabolism. 1975; 24:1085–1102.
3. Ishibazawa A, Nagaoka T, Takahashi A, et al. Optical coherence tomography angiography in diabetic retinopathy: a prospective pilot study. Am J Ophthalmol. 2015; 160:35–44.
Article
4. Al-Sheikh M, Akil H, Pfau M, Sadda SR. Swept-source OCT angiography imaging of the foveal avascular zone and macular capillary network density in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2016; 57:3907–3913.
5. de Carlo TE, Chin AT, Bonini Filho MA, et al. Detection of microvascular changes in eyes of patients with diabetes but not clinical diabetic retinopathy using optical coherence tomography angiography. Retina. 2015; 35:2364–2370.
Article
6. Ferris FL 3rd. Photocoagulation for diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group. JAMA. 1991; 266:1263–1265.
7. Okamoto M, Matsuura T, Ogata N. Effects of panretinal photocoagulation on choroidal thickness and choroidal blood flow in patients with severe nonproliferative diabetic retinopathy. Retina. 2016; 36:805–811.
Article
8. Stefansson E. Oxygen and diabetic eye disease. Graefes Arch Clin Exp Ophthalmol. 1990; 228:120–123.
9. Spaide RF, Klancnik JM Jr, Cooney MJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol. 2015; 133:45–50.
Article
10. Lim HB, Kim YW, Kim JM, et al. The importance of signal strength in quantitative assessment of retinal vessel density using optical coherence tomography angiography. Sci Rep. 2018; 8:12897.
11. Nonaka A, Kiryu J, Tsujikawa A, et al. Inflammatory response after scatter laser photocoagulation in nonphotocoagulated retina. Invest Ophthalmol Vis Sci. 2002; 43:1204–1209.
12. Grunwald JE, Brucker AJ, Petrig BL, Riva CE. Retinal blood flow regulation and the clinical response to panretinal photocoagulation in proliferative diabetic retinopathy. Ophthalmology. 1989; 1518–1522.
13. Chey JH, Park JM. Retinal vascular caliber changes in diabetic retinopathy after panretinal photocoagulation and additive bevacizumab injections. J Korean Ophthalmol Soc. 2016; 57:917–923.
Article
14. Yang HS, Kim JG, Cha JB, et al. Quantitative analysis of neural tissues around the optic disc after panretinal photocoagulation in patients with diabetic retinopathy. PLoS One. 2017; 12:e0186229.
15. Türk A, Esenülkü CM, Akyol N, et al. Pulsatile ocular blood flow changes after panretinal photocoagulation treatment in patients with proliferative diabetic retinopathy. Turk J Med Sci. 2014; 44:524–529.
Article
16. Lee JC, Wong BJ, Tan O, et al. Pilot study of doppler optical coherence tomography of retinal blood flow following laser photocoagulation in poorly controlled diabetic patients. Invest Ophthalmol Vis Sci. 2013; 54:6104–6111.
17. Arvas S, Ocakoglu O, Ozkan S. The capillary blood flow in ischaemic type central retinal vein occlusion: the effect of laser photocoagulation. Acta Ophthalmol Scand. 2002; 80:490–494.
Article
18. Lorusso M, Milano V, Nikolopoulou E, et al. Panretinal photocoagulation does not change macular perfusion in eyes with proliferative diabetic retinopathy. Ophthalmic Surg Lasers Imaging Retina. 2019; 50:174–178.
19. Kim JT, Lee DH, Joe SG, et al. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients. Invest Ophthalmol Vis Sci. 2013; 54:3378–3384.
Article
20. Cho GE, Cho HY, Kim YT. Change in subfoveal choroidal thickness after argon laser panretinal photocoagulation. Int J Ophthalmol. 2013; 6:505–509.
21. Park BJ, Chung HW, Kim HC. Effects of diabetic retinopathy and intravitreal bevacizumab injection on choroidal thickness in diabetic patients. J Korean Ophthalmol Soc. 2013; 54:1520–1525.
Article